Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
The American Journal of Surgical Pathology|December 1, 1992
Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative GroupG L Ottesen, H P Graversen, M Blichert-Toft, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Fetal antigen 2 in primary and secondary brain tumorsH B Rasmussen, B Teisner, H D Schrøder, et al.Journal of Cutaneous Pathology|June 1, 1991
Immunohistochemical studies on the localization of fetal antigen 2 (FA2), laminin, and collagen type 4 in basal cell carcinomaH B Rasmussen, B Teisner, J A Andersen, et al.International Journal of Cancer|September 27, 1995
Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patientsM R Teixeira, N Pandis, G Bardi, et al.Breast Cancer Research and Treatment|November 10, 2000
Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide studyG L Ottesen, H P Graversen, M Blichert-Toft, et al.Fertility and Sterility|April 1, 1996
Ectopic pregnancy: histopathology and assessment of cell proliferation with and without methotrexate treatmentC Floridon, O Nielsen, C Byrjalsen, et al.British Journal of Cancer|November 1, 1994
Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour fociM R Teixeira, N Pandis, G Bardi, et al.Cytometry|September 15, 1995
DNA analysis of in situ ductal carcinoma of the breast via flow cytometryG L Ottesen, I J Christensen, J K Larsen, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 1, 1992
Foetal antigen 2 (FA2) in the stromal reaction induced by breast carcinomaH B Rasmussen, B Teisner, J A Andersen, et al.Breast Cancer Research and Treatment|January 1, 1983
Antiestrogen treatment of postmenopausal women with primary high risk breast cancerC Rose, S M Thorpe, H T Mouridsen, et al.Pageof 9